Incyte - 26 Year Stock Price History | INCY

Historical daily share price chart and data for Incyte since 1993 adjusted for splits. The latest closing stock price for Incyte as of October 17, 2019 is 77.43.
  • The all-time high Incyte stock closing price was 152.66 on March 15, 2017.
  • The Incyte 52-week high stock price is 89.30, which is 15.3% above the current share price.
  • The Incyte 52-week low stock price is 57.00, which is 26.4% below the current share price.
  • The average Incyte stock price for the last 52 weeks is 77.46.
Incyte Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 80.4784 63.5600 88.7000 63.5600 77.4300 21.76%
2018 72.8748 100.8900 100.9800 58.5000 63.5900 -32.86%
2017 121.3776 102.3200 152.6600 93.5600 94.7100 -5.55%
2016 83.5442 103.3200 108.1000 63.0500 100.2700 -7.54%
2015 102.6879 73.7600 131.4700 71.4900 108.4500 48.34%
2014 57.1143 51.2300 78.8900 43.1000 73.1100 44.40%
2013 28.9761 17.0000 51.3400 17.0000 50.6300 204.82%
2012 19.2983 14.9900 25.8400 14.7800 16.6100 10.66%
2011 15.7089 16.5200 20.7600 11.7800 15.0100 -9.36%
2010 13.4671 9.5000 17.1700 9.4100 16.5600 81.78%
2009 4.7656 3.8500 9.4000 2.0500 9.1100 140.37%
2008 8.3997 9.9800 12.4200 2.4900 3.7900 -62.29%
2007 7.1488 6.0200 10.7800 4.8100 10.0500 72.09%
2006 4.8336 5.3400 6.2000 3.5800 5.8400 9.36%
2005 7.1163 9.6400 9.6600 4.2700 5.3400 -46.55%
2004 8.3024 6.8200 10.9600 5.4500 9.9900 46.05%
2003 4.6662 4.9090 6.9100 2.6700 6.8400 50.00%
2002 8.0137 19.4000 19.6900 2.9800 4.5600 -76.54%
2001 18.1810 22.5600 30.6300 10.7600 19.4400 -21.86%
2000 47.9850 44.8150 140.2500 23.5600 24.8800 -17.07%
1999 12.9288 18.5000 31.5650 8.2800 30.0000 60.51%
1998 17.8036 21.3750 25.1900 9.2500 18.6900 -16.93%
1997 16.6527 12.7500 22.5000 10.6250 22.5000 74.76%
1996 9.2842 7.0300 12.8750 6.1250 12.8750 106.00%
1995 4.4132 3.4075 6.2500 3.2825 6.2500 80.12%
1994 2.4212 2.1875 3.9075 1.7188 3.4700 54.22%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $16.887B $1.882B
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. Their first commercial product, Jakafi (ruxolitinib), is approved in the United States for patients with intermediate or high-risk myelofibrosis and for patients with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea. They have a diverse and growing portfolio of product candidates, including both small and large molecules.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.735B 13.98
Gilead Sciences (GILD) United States $82.700B 10.16
CSL (CSLLY) Australia $76.695B 0.00
Celgene (CELG) United States $71.547B 11.07
Illumina (ILMN) United States $45.889B 53.92
Vertex Pharmaceuticals (VRTX) United States $45.274B 48.93
Biogen (BIIB) United States $41.696B 7.41
Regeneron Pharmaceuticals (REGN) United States $33.369B 15.15
Alexion Pharmaceuticals (ALXN) United States $23.501B 12.39
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.152B 0.00
Seattle Genetics (SGEN) United States $13.484B 0.00
Exact Sciences (EXAS) United States $12.915B 0.00
Genmab (GNMSF) Denmark $12.585B 70.59
BioMarin Pharmaceutical (BMRN) United States $12.295B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.647B 51.72
Alnylam Pharmaceuticals (ALNY) United States $8.991B 0.00
Galapagos (GLPG) Belgium $8.891B 0.00
Bio-Techne Corp (TECH) United States $7.603B 52.52
Sarepta Therapeutics (SRPT) United States $6.546B 0.00
QIAGEN (QGEN) Netherlands $6.202B 20.37
Guardant Health (GH) United States $6.106B 0.00
BeiGene (BGNE) Cayman Islands $5.927B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.803B 0.00
Amarin (AMRN) Ireland $5.665B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.257B 13.36
Exelixis (EXEL) United States $5.086B 13.22
Bluebird Bio (BLUE) United States $4.949B 0.00
Reata Pharmaceuticals (RETA) United States $4.754B 0.00
Moderna (MRNA) United States $4.732B 0.00
China Biologic Products (CBPO) China $4.544B 28.37
ARGENX SE-ADR (ARGX) Netherlands $4.438B 0.00
Ascendis Pharma (ASND) Denmark $4.244B 0.00
Medicines (MDCO) United States $4.212B 0.00
Repligen (RGEN) United States $4.082B 79.22
Spark Therapeutics (ONCE) United States $3.813B 0.00
Blueprint Medicines (BPMC) United States $3.659B 0.00
MorphoSys AG (MOR) Germany $3.449B 0.00
Mirati Therapeutics (MRTX) United States $3.083B 0.00
Alkermes (ALKS) Ireland $2.892B 0.00
Emergent Biosolutions (EBS) United States $2.798B 42.04
Immunomedics (IMMU) United States $2.763B 0.00
Genomic Health (GHDX) United States $2.659B 49.87
Genmab (GMAB) Denmark $2.639B 0.00
MyoKardia (MYOK) United States $2.528B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.467B 0.00
Arena Pharmaceuticals (ARNA) United States $2.436B 5.24
Halozyme Therapeutics (HALO) United States $2.325B 0.00
RA PHARMCTL INC (RARX) United States $2.210B 0.00
Acceleron Pharma (XLRN) United States $2.209B 0.00
Myriad Genetics (MYGN) United States $2.203B 23.12
NeoGenomics (NEO) United States $2.103B 112.50
Intercept Pharmaceuticals (ICPT) United States $2.101B 0.00
Amicus Therapeutics (FOLD) United States $2.101B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.075B 0.00
Ligand Pharmaceuticals (LGND) United States $2.050B 25.92
Cambrex (CBM) United States $2.010B 25.40
Zai Lab (ZLAB) China $1.962B 0.00
Akcea Therapeutics (AKCA) United States $1.874B 0.00
UniQure (QURE) Netherlands $1.684B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.583B 0.00
Insmed (INSM) United States $1.559B 0.00
Denali Therapeutics (DNLI) United States $1.442B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.431B 0.00
REGENXBIO (RGNX) United States $1.388B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.357B 0.00
Coherus BioSciences (CHRS) United States $1.318B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.109B 0.00
Zymeworks (ZYME) Canada $1.105B 0.00
Innoviva (INVA) United States $1.103B 3.19
Dicerna Pharmaceuticals (DRNA) United States $1.025B 0.00
Alector (ALEC) United States $1.013B 0.00
Editas Medicine (EDIT) United States $1.004B 0.00
AnaptysBio (ANAB) United States $0.973B 0.00
Sangamo Therapeutics (SGMO) United States $0.972B 0.00
Fate Therapeutics (FATE) United States $0.964B 0.00
Epizyme (EPZM) United States $0.935B 0.00
Zealand Pharma (ZEAL) Denmark $0.877B 9.84
ANI Pharmaceuticals (ANIP) United States $0.870B 14.52
Athenex (ATNX) United States $0.857B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.805B 0.00
Codexis (CDXS) United States $0.802B 0.00
Anika Therapeutics (ANIK) United States $0.791B 28.00
Pharming Group (PHGUF) Netherlands $0.782B 0.00
Cara Therapeutics (CARA) United States $0.776B 0.00
Twist Bioscience (TWST) United States $0.763B 0.00
WAVE Life Sciences (WVE) Singapore $0.723B 0.00
Principia Biopharma (PRNB) United States $0.722B 373.88
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.721B 26.02
ZIOPHARM Oncology Inc (ZIOP) United States $0.707B 0.00
Cytokineticsorporated (CYTK) United States $0.681B 0.00
Vericel (VCEL) United States $0.669B 0.00
Revance Therapeutics (RVNC) United States $0.647B 0.00
Mesoblast (MESO) Australia $0.598B 0.00
Heska (HSKA) United States $0.576B 74.67
Arvinas (ARVN) United States $0.564B 0.00
Intellia Therapeutics (NTLA) United States $0.555B 0.00
MiMedx (MDXG) United States $0.554B 0.00
GENFIT S.A (GNFT) France $0.545B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.510B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.487B 0.00
PHARMA MAR SA (PHMMF) Spain $0.485B 0.00
Retrophin (RTRX) United States $0.483B 0.00
UROGEN PHARMA (URGN) United States $0.463B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
DBV Technologies S.A (DBVT) France $0.460B 0.00
Intra-Cellular Therapies (ITCI) United States $0.454B 0.00
BioDelivery Sciences (BDSI) United States $0.445B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.431B 0.00
Cellectis S.A (CLLS) France $0.429B 0.00
Adverum Biotechnologies (ADVM) United States $0.411B 0.00
Syros Pharmaceuticals (SYRS) United States $0.397B 0.00
Stemline Therapeutics (STML) United States $0.391B 0.00
Bellus Health (BLU) Canada $0.390B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.387B 0.00
Merus (MRUS) Netherlands $0.375B 0.00
Arcus Biosciences (RCUS) United States $0.369B 0.00
Agenus (AGEN) United States $0.363B 0.00
Precision BioSciences (DTIL) United States $0.348B 0.00
Kadmon Holdings (KDMN) United States $0.345B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.340B 0.00
AC Immune SA (ACIU) Switzerland $0.332B 24.55
Prothena (PRTA) Ireland $0.328B 0.00
CytomX Therapeutics (CTMX) United States $0.325B 0.00
Protagonist Therapeutics (PTGX) United States $0.308B 0.00
Gritstone Oncology (GRTS) United States $0.307B 0.00
Cellular Biomedicine (CBMG) United States $0.294B 0.00
Kindred Biosciences (KIN) United States $0.294B 0.00
Cel-Sci (CVM) United States $0.291B 0.00
Avid Bioservices (CDMO) United States $0.283B 0.00
Geron (GERN) United States $0.283B 0.00
Theratechnologies (THTX) Canada $0.282B 0.00
Pfenex (PFNX) United States $0.281B 0.00
Starpharma Holdings (SPHRY) Australia $0.279B 0.00
Scholar Rock Holding (SRRK) United States $0.278B 0.00
Dynavax Technologies (DVAX) United States $0.274B 0.00
PDL BioPharma (PDLI) United States $0.274B 7.06
Biofrontera AG (BFRA) Germany $0.265B 395.33
Puma Biotechnology (PBYI) United States $0.264B 0.00
ADMA Biologics Inc (ADMA) United States $0.247B 0.00
MannKind (MNKD) United States $0.241B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.239B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.228B 0.00
Albireo Pharma (ALBO) United States $0.227B 0.00
Seres Therapeutics (MCRB) United States $0.224B 0.00
Inovio Pharmaceuticals (INO) United States $0.222B 0.00
OSMOTICA PHARM (OSMT) United States $0.221B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.220B 0.00
Sutro Biopharma (STRO) United States $0.218B 0.00
Sorrento Therapeutics (SRNE) United States $0.215B 0.00
Compugen (CGEN) Israel $0.211B 0.00
Athersys (ATHX) United States $0.208B 0.00
Spero Therapeutics (SPRO) United States $0.205B 0.00
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Kamada (KMDA) Israel $0.203B 7.74
Exicure (XCUR) United States $0.201B 0.00
Palatin Technologies (PTN) United States $0.191B 5.60
Affimed (AFMD) Germany $0.183B 0.00
Dyadic (DYAI) United States $0.181B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.180B 0.00
ChromaDex (CDXC) United States $0.180B 0.00
Clovis Oncology (CLVS) United States $0.175B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.169B 0.00
Senesco Technologies (ELOX) United States $0.167B 0.00
Cue Biopharma (CUE) United States $0.166B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Enzo Biochem (ENZ) United States $0.160B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.159B 0.00
XOMA (XOMA) United States $0.158B 0.00
Arsanis (XFOR) United States $0.154B 0.00
Cerecor (CERC) United States $0.153B 0.00
Five Prime Therapeutics (FPRX) United States $0.152B 0.00
Alcobra (ARCT) United States $0.151B 0.00
BioTime (LCTX) United States $0.142B 9.49
CorMedix Inc (CRMD) United States $0.134B 0.00
Abeona Therapeutics (ABEO) United States $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.133B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.132B 0.00
Emmaus Life Sciences (EMMA) United States $0.131B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.130B 0.00
NantKwest (NK) United States $0.124B 0.00
PHASEBIO PHARMA (PHAS) United States $0.123B 0.00
Acorda Therapeutics (ACOR) United States $0.123B 0.00
SESEN BIO, INC (SESN) United States $0.122B 0.00
Novavax (NVAX) United States $0.116B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
Menlo Therapeutics (MNLO) United States $0.110B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.109B 0.00
Aptinyx (APTX) United States $0.108B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.107B 0.00
Strongbridge Biopharma (SBBP) United States $0.107B 4.38
Celyad SA (CYAD) Belgium $0.097B 0.00
OvaScience (MLND) United States $0.096B 0.00
VBI Vaccines (VBIV) United States $0.094B 0.00
Fortress Biotech (FBIO) United States $0.090B 0.00
Trevena (TRVN) United States $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
Vaccinex (VCNX) United States $0.083B 0.00
Verastem (VSTM) United States $0.082B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.080B 0.00
Checkpoint Therapeutics (CKPT) United States $0.080B 0.00
Aduro Biotech (ADRO) United States $0.080B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
ARAVIVE, INC (ARAV) United States $0.079B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Liquidia Technologies (LQDA) United States $0.077B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.075B 0.00
Mersana Therapeutics (MRSN) United States $0.075B 0.00
Prima BioMed (IMMP) Australia $0.071B 0.00
Curis (CRIS) United States $0.069B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.069B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Selecta Biosciences (SELB) United States $0.061B 0.00
Arbutus Biopharma (ABUS) Canada $0.058B 0.00
Applied Genetic Technologies (AGTC) United States $0.058B 0.00
Pluristem Therapeutics (PSTI) Israel $0.057B 0.00
Orgenesis (ORGS) United States $0.057B 20.88
Merrimack Pharmaceuticals (MACK) United States $0.057B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.056B 0.00
AquaBounty Technologies (AQB) United States $0.054B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.054B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.053B 0.00
VistaGen Therapeutics (VTGN) United States $0.051B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.050B 0.00
Unum Therapeutics (UMRX) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
AIT Therapeutics (XAIR) United States $0.047B 0.00
NewLink Genetics (NLNK) United States $0.047B 0.00
Stellar Biotechnologies (EDSA) Canada $0.043B 0.00
Evogene (EVGN) Israel $0.042B 0.00
VIVUS (VVUS) United States $0.042B 0.00
Ophthotech (ISEE) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
Oncobiologics (OTLK) United States $0.040B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.039B 0.00
Proteostasis Therapeutics (PTI) United States $0.039B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
Entera Bio (ENTX) Israel $0.033B 0.00
Clearside Biomedical (CLSD) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.90
Alimera Sciences (ALIM) United States $0.028B 0.00
Protalix BioTherapeutics (PLX) Israel $0.027B 0.00
Signal Genetics (MGEN) United States $0.026B 0.00
DiaMedica Therapeutics (DMAC) United States $0.025B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Apricus Biosciences (SEEL) United States $0.020B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.020B 0.00
Soligenix (SNGX) United States $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Prana Biotechnology (ATHE) Australia $0.017B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
Pulmatrix (PULM) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Cleveland BioLabs (CBLI) United States $0.010B 0.00
IBio (IBIO) United States $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
TrovaGene (TROV) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (CUR) United States $0.003B 0.00